Gipuzkoa
Campus
![Foto de Gipuzkoa](/img/uploaded/FCB09D7335FCA2A3AE8EE86EE65B5B3A.jpg)
![Foto de Marche Polytechnic University](/img/noimage_org.png)
Marche Polytechnic University
Ancona, ItaliaPublicaciones en colaboración con investigadoras/es de Marche Polytechnic University (25)
2022
-
Cholangiocarcinoma landscape in Europe: Diagnostic, prognostic and therapeutic insights from the ENSCCA Registry
Journal of Hepatology, Vol. 76, Núm. 5, pp. 1109-1121
-
TREM-2 plays a protective role in cholestasis by acting as a negative regulator of inflammation
Journal of Hepatology, Vol. 77, Núm. 4, pp. 991-1004
2021
-
Inhibition of NAE-dependent protein hyper-NEDDylation in cystic cholangiocytes halts cystogenesis in experimental models of polycystic liver disease
United European Gastroenterology Journal, Vol. 9, Núm. 7, pp. 848-859
-
Targeting UBC9-mediated protein hyper-SUMOylation in cystic cholangiocytes halts polycystic liver disease in experimental models
Journal of Hepatology, Vol. 74, Núm. 2, pp. 394-406
2020
-
Cholangiocarcinoma 2020: the next horizon in mechanisms and management
Nature Reviews Gastroenterology and Hepatology, Vol. 17, Núm. 9, pp. 557-588
-
Designing single-molecule magnets as drugs with dual anti-inflammatory and anti-diabetic effects
International Journal of Molecular Sciences, Vol. 21, Núm. 9
-
Proteostasis disturbances and endoplasmic reticulum stress contribute to polycystic liver disease: New therapeutic targets
Liver International, Vol. 40, Núm. 7, pp. 1670-1685
2019
-
Wnt–β-catenin signalling in liver development, health and disease
Nature Reviews Gastroenterology and Hepatology, Vol. 16, Núm. 2, pp. 121-136
2018
-
Differential effects of FXR or TGR5 activation in cholangiocarcinoma progression
Biochimica et Biophysica Acta - Molecular Basis of Disease, Vol. 1864, Núm. 4, pp. 1335-1344
-
MicroRNA-506 promotes primary biliary cholangitis–like features in cholangiocytes and immune activation
Hepatology, Vol. 67, Núm. 4, pp. 1420-1440
2017
-
Bile Acids in Polycystic Liver Diseases: Triggers of Disease Progression and Potential Solution for Treatment
Digestive Diseases, Vol. 35, Núm. 3, pp. 275-281
-
New Advances in Polycystic Liver Diseases
Seminars in Liver Disease
-
SOX17 regulates cholangiocyte differentiation and acts as a tumor suppressor in cholangiocarcinoma
Journal of Hepatology, Vol. 67, Núm. 1, pp. 72-83
-
Serum extracellular vesicles contain protein biomarkers for primary sclerosing cholangitis and cholangiocarcinoma
Hepatology, Vol. 66, Núm. 4, pp. 1125-1143
-
The orness value for rank-dependent welfare functions and rank-dependent poverty measures
Fuzzy Sets and Systems, Vol. 325, pp. 114-136
2016
-
Expert consensus document: Cholangiocarcinoma: current knowledge and future perspectives consensus statement from the European Network for the Study of Cholangiocarcinoma (ENS-CCA)
Nature Reviews Gastroenterology and Hepatology, Vol. 13, Núm. 5, pp. 261-280
-
The decompositions of rank-dependent poverty measures using ordered weighted averaging operators
International Journal of Approximate Reasoning, Vol. 76, pp. 47-62
2015
-
Ursodeoxycholic acid inhibits hepatic cystogenesis in experimental models of polycystic liver disease
Journal of Hepatology, Vol. 63, Núm. 4, pp. 952-961
2014
-
Inhibition of metalloprotease hyperactivity in cystic cholangiocytes halts the development of polycystic liver diseases
Gut, Vol. 63, Núm. 10, pp. 1658-1667
-
Polycystic liver diseases: Advanced insights into the molecular mechanisms
Nature Reviews Gastroenterology and Hepatology, Vol. 11, Núm. 12, pp. 750-761